116 related articles for article (PubMed ID: 2424468)
21. Modulation of production of hepatitis B surface antigen by a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P; Calegari L
J Med Virol; 1984; 13(2):117-23. PubMed ID: 6198456
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and characterization of the cDNA coding for hepatitis B virus surface antigen.
He BG; Melnick JL; Siddiqui A; Robinson WS; Law SW; Lai EC
Sci Sin B; 1985 Jan; 28(1):49-59. PubMed ID: 2984765
[TBL] [Abstract][Full Text] [Related]
23. Characterization of hepatitis B virus DNA polymerase.
Goto Y; Yamashita T; Arens M; Takahashi T; Hashimoto T
Jpn J Med Sci Biol; 1984 Feb; 37(1):9-18. PubMed ID: 6204081
[TBL] [Abstract][Full Text] [Related]
24. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line.
Manzin A; Bagnarelli P; Brugia M; Pauri P; Clementi M
Ric Clin Lab; 1986; 16(3):457-62. PubMed ID: 2433727
[TBL] [Abstract][Full Text] [Related]
26. Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus.
Petcu DJ; Aldrich CE; Coates L; Taylor JM; Mason WS
Virology; 1988 Dec; 167(2):385-92. PubMed ID: 2462306
[TBL] [Abstract][Full Text] [Related]
27. Relation between HBsAg binding with polymerized human serum albumin and HBV replication.
Irshad M; Gandhi BM; Acharya SK; Tandon BN
Intervirology; 1987; 27(2):91-4. PubMed ID: 3667186
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hepatitis B virus surface gene expression by antisense oligodeoxynucleotides in a human hepatoma cell line.
Reinis M; Reinisová M; Korec E; Hlozánek I
Folia Biol (Praha); 1993; 39(5):262-9. PubMed ID: 8206172
[TBL] [Abstract][Full Text] [Related]
29. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus gene expression in two cell lines, one derived from a natural human infection, the other experimentally infected in vitro.
Aspinall S; Alexander JJ
S Afr Med J; 1985 Nov; 68(10):751-4. PubMed ID: 2414854
[TBL] [Abstract][Full Text] [Related]
31. Effects of human leucocyte interferon on hepatitis B virus replication and immune responses in patients with chronic hepatitis B infection.
Scullard GH; Alberti A; Wansbrough-Jones MH; Howard CR; Eddleston AL; Zuckerman AJ; Cantell K; Williams R
J Clin Lab Immunol; 1979 Feb; 1(4):277-82. PubMed ID: 501726
[TBL] [Abstract][Full Text] [Related]
32. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
33. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.
Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217
[TBL] [Abstract][Full Text] [Related]
34. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.
Edman JC; Gray P; Valenzuela P; Rall LB; Rutter WJ
Nature; 1980 Jul; 286(5772):535-8. PubMed ID: 6250075
[TBL] [Abstract][Full Text] [Related]
35. Effect of interferon on the production of HBsAg and induction of an antiviral state in human hepatoma cell line PLC/PRF/5.
Nakajima Y; Kuwata T; Tomita Y; Okuda K
Microbiol Immunol; 1982; 26(8):705-12. PubMed ID: 6294485
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
[TBL] [Abstract][Full Text] [Related]
37. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
38. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.
Marcellin P; Martinot-Peignoux M; Loriot MA; Giostra E; Boyer N; Thiers V; Benhamou JP
Ann Intern Med; 1990 Feb; 112(3):227-8. PubMed ID: 2297196
[No Abstract] [Full Text] [Related]
39. [Evaluation of the antiviral activity of medicinal plants against the hepatitis B virus (HBV) in PLC/PRF/5 cells].
González González RL; Roque Quintero A; Morier Díaz L; Rodríguez Lay Lde L
Rev Cubana Med Trop; 2006; 58(2):103-8. PubMed ID: 23427427
[TBL] [Abstract][Full Text] [Related]
40. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
